MT2- 10MG
$9.33
MT2 (10 mg) — melanocortin receptor agonist analogue studied for its activity in receptor-mediated signaling related to melanocortin system pathways and pigmentation-associated cellular processes. Research use only.
Test Results
Research-use onlyValues shown are provided for identity/quality verification only. No medical, clinical, or functional claims are made or implied.
In stock
MT2 — Research Peptide
Description
MT2 is a proprietary code-designated peptide analogue within the melanocortin receptor research class.
It has been studied for its activity at melanocortin receptor sites, supporting investigations into receptor-mediated signaling pathways associated with pigmentation-related processes and regulatory peptide interactions.
In experimental models, this receptor activity has been evaluated for its influence on melanocortin system signaling dynamics and adaptive cellular response mechanisms.
MT2 is of growing interest in in-vitro research focused on melanocortin receptor pharmacology and peptide-receptor interaction studies.
This material is supplied in lyophilized powder form and intended strictly for in-vitro and laboratory research by qualified professionals.
Specifications
- Form: Lyophilized peptide (powder)
- Purity: ≥ 99% (HPLC verified)
- Storage: −20 °C or below; avoid repeated freeze–thaw cycles
- Solvent: Reconstitute with sterile bacteriostatic water (for research use only)
- Molecular Class: Melanocortin receptor agonist analogue
- CAS Reference: Available upon request
Available Variants
- 10 mg vial
Disclaimer
For research use only. Not for human or animal consumption, therapeutic use, or diagnostic procedures.
By purchasing, the customer confirms they are a qualified researcher and understands the intended use.